Kyoto, Japan

Tomomi Shigeno

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Maruho Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomomi Shigeno. Retrieved from https://idiyas.com/inventor/tomomi-shigeno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomomi Shigeno: Innovator in Transdermal Administration

Introduction

Tomomi Shigeno is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of topical agents for transdermal administration. Her innovative work aims to enhance the effectiveness of drug delivery systems.

Latest Patents

Tomomi Shigeno holds a patent for a topical agent designed for transdermal administration. This invention focuses on improving the transdermal absorbability of cyclosporine, a medication often used for its immunosuppressive properties. The patent describes an external preparation that contains cyclosporine and a ketone, which enhances its absorption through the skin.

Career Highlights

Shigeno is associated with Maruho Co., Ltd., a company known for its dedication to dermatological products and innovations. Her work at Maruho has positioned her as a key player in the development of advanced pharmaceutical formulations.

Collaborations

Tomomi Shigeno has collaborated with notable colleagues, including Hiroki Sakiyama and Noriaki Kaneda. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.

Conclusion

Tomomi Shigeno's contributions to transdermal drug delivery systems exemplify her commitment to advancing pharmaceutical science. Her innovative patent reflects her expertise and dedication to improving patient care through effective medication delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…